newsfilter
← Latest News
GlobeNewswire·

NewGenIvf Group Limited Announces Closing of $2.5 Million Underwritten Offering

  • NewGenIvf Group Limited closed a firm commitment underwritten offering on November 20, 2026, with gross proceeds of approximately $2.5 million.
  • The offering consisted of 9,501,148 Class A Ordinary Shares & Pre-Funded Warrants to purchase up to 61,927,422 Class A Ordinary Shares.
  • The offering price was $0.035 per Class A Ordinary Share & $0.03499 per Pre-Funded Warrant.
  • Net proceeds will be used for commercialization of Nodexus cytometry technology, expansion of assisted reproductive services, strategic investments in prediction-market & digital-asset/AI initiatives, UAE real estate interests, & general corporate purposes.
  • Approximately $625,000 of gross proceeds will be applied to repurchase $584,112 in principal amount of the Exchange Note.
  • Aegis Capital Corp. served as the sole book-running manager for the transaction.
  • The offering was executed pursuant to an effective shelf registration statement on Form F-3 filed with the SEC.
  • NewGenIvf Group Limited is listed on the Nasdaq Capital Market under the symbol "NIVF".
Company
NewGenIvf Limited
Keywords
Nasdaq:NIVF, NewGenIvf Limited